Skip to main content

Uterine (Including Endometrial) Cancer Clinical Trials

Review the uterine (including endometrial) cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 151-175 of 311

Fenofibrate for the Treatment of Patients with Cervical Dysplasia or Invasive Cervical Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Cancer Patients
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Zanzalintinib in Combination with Paclitaxel for the Treatment of Recurrent High Grade Uterine Cancer
Status: Active
Location: 2 locations
A Theranostic Approach ([68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G) for the Detection and Treatment of Metastatic Cancers
Status: Active
Location: University of California Davis Comprehensive Cancer Center, Sacramento, California
KK-LC-1 TCR T Cells for the Treatment of Metastatic Gastric, Lung, Breast, and Cervical Cancers
Status: Active
Location: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Combination ONC201 and Atezolizumab for the Treatment of Metastatic or Recurrent Obesity-Driven Endometrial Cancer
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Status: Active
Location: 3 locations
E7 TCR-T Cell Induction Therapy for the Treatment of Locoregionally Advanced HPV-Associated Cancers
Status: Active
Location: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
Tumor Treating Fields Therapy in Combination with Chemotherapy for the Treatment of Advanced Solid Tumors Involving the Abdomen or Thorax
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
IACS-6274 with or without Bevacizumab and Paclitaxel or Capivasertib for the Treatment of Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Status: Active
Location: Northwestern University, Chicago, Illinois
FIH Study to Evaluate Safety, Tolerability, PK, PD & Preliminary Efficacy of AT03-65 With Advanced Solid Tumors
Status: Active
Location: OHSU Knight Cancer Institute, Portland, Oregon
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Status: Active
Location: 2 locations
Y-NM600 in Combination with Immune Checkpoint Inhibitors in Treating Patients with Metastatic Cancer
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
Pomalidomide and Nivolumab for the Treatment of Virus-Associated Malignancies with or without HIV
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Clinical Trial of PM54 in Advanced Solid Tumors Patients.
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
A Study of MGC026 in Participants With Advanced Solid Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Three Fraction Brachytherapy versus Four Fraction Brachytherapy for the Treatment of Cervical Cancer, BRACHY-FIT Trial
Status: Active
Location: Stanford Cancer Institute Palo Alto, Palo Alto, California
Physical Therapy and Coping Skills Training for Improving Women's Sexual Function after Pelvic Radiation
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Magnetic Resonance Imaging-Guided Brachytherapy in Treating Patients with Gynecologic Cancers
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer
Status: Active
Location: See ClinicalTrials.gov
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington